• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domain.

作者信息

Stratton-Thomas J R, Min H Y, Kaufman S E, Chiu C Y, Mullenbach G T, Rosenberg S

机构信息

Chiron Corporation, Emeryville, CA 94608, USA.

出版信息

Protein Eng. 1995 May;8(5):463-70. doi: 10.1093/protein/8.5.463.

DOI:10.1093/protein/8.5.463
PMID:8532668
Abstract

The human urokinase plasminogen activator (uPA) epidermal growth factor-like domain (residues 1-48) and a variant with a C-terminal epitope tag have been secreted from recombinant yeast. Purified human uPA 1-48 and uPA 1-48glu complete for binding to the human uPA receptor with Kds of 180 and 400 pM respectively, in an in vitro assay using an immobilized recombinant uPA receptor. A synthetic gene encoding human uPA 1-48 with an N-terminal epitope tag was inserted into a phagemid expression vector as a fusion with residues 249-406 of the M13 pIII protein with an intervening amber codon (TAG). Phagemid production led to infectious particles which were selectively bound and eluted from both epitope tag antibody and urokinase receptor. Sequential binding to this antibody and receptor demonstrated a substantial enrichment, where up to 10% of the infectious particles were then retained on urokinase receptor-coated plates. A PCR strategy was used to convert previously described peptide bacteriophage ligands for the urokinase receptor to phagemid display. The yields of these peptide phagemids and the uPA 1-48 phagemid showed a correlation with peptide affinity, in contrast to when the peptides are multivalently displayed on a bacteriophage.

摘要

相似文献

1
Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domain.
Protein Eng. 1995 May;8(5):463-70. doi: 10.1093/protein/8.5.463.
2
Ligand binding regions in the receptor for urokinase-type plasminogen activator.尿激酶型纤溶酶原激活剂受体中的配体结合区域。
J Biol Chem. 2001 Aug 3;276(31):28946-53. doi: 10.1074/jbc.m011347200.
3
A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.尿激酶生长因子结构域与2型纤溶酶原激活物抑制剂的杂合蛋白可抑制尿激酶活性,并与尿激酶受体结合。
Eur J Biochem. 1992 Jul 1;207(1):177-83. doi: 10.1111/j.1432-1033.1992.tb17035.x.
4
Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator.人尿激酶型纤溶酶原激活剂受体结合区域的系统突变分析
Eur J Biochem. 1996 May 1;237(3):743-51. doi: 10.1111/j.1432-1033.1996.0743p.x.
5
A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.一种用于研究尿激酶型纤溶酶原激活剂与其受体功能相互作用的竞争性显色测定法。
Biol Chem Hoppe Seyler. 1995 Oct;376(10):587-94. doi: 10.1515/bchm3.1995.376.10.587.
6
Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.人尿激酶型纤溶酶原激活剂与其受体的结合:涉及物种特异性和结合的残基。
Arterioscler Thromb Vasc Biol. 1998 May;18(5):693-701. doi: 10.1161/01.atv.18.5.693.
7
Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide.纤溶酶原激活物抑制剂1衍生肽对单链尿激酶结合、内化及降解的调节作用
J Biol Chem. 1997 Oct 24;272(43):27053-7. doi: 10.1074/jbc.272.43.27053.
8
High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.通过噬菌体肽展示技术鉴定出的高亲和力尿激酶受体拮抗剂。
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7129-33. doi: 10.1073/pnas.91.15.7129.
9
Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.尿激酶型纤溶酶原激活剂通过不同的受体依赖性和蛋白水解依赖性机制诱导人平滑肌细胞迁移和增殖。
Mol Cell Biochem. 1999 May;195(1-2):199-206. doi: 10.1023/a:1006936623106.
10
Binding of urokinase plasminogen activator to gp130 via a putative urokinase-binding consensus sequence.
Biol Chem. 2003 Feb;384(2):229-36. doi: 10.1515/BC.2003.025.

引用本文的文献

1
Surface display of glycosylated Tyrosinase related protein-2 (TRP-2) tumour antigen on Lactococcus lactis.糖基化酪氨酸酶相关蛋白2(TRP-2)肿瘤抗原在乳酸乳球菌上的表面展示
BMC Biotechnol. 2015 Dec 29;15:113. doi: 10.1186/s12896-015-0231-z.
2
Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.通过一种适体以新颖的多功能机制抑制尿激酶型纤溶酶原激活物,从而在体内靶向肿瘤细胞侵袭和扩散。
Mol Cancer Res. 2012 Dec;10(12):1532-43. doi: 10.1158/1541-7786.MCR-12-0349. Epub 2012 Oct 4.
3
Mimicry of the regulatory role of urokinase in lamellipodia formation by introduction of a non-native interdomain disulfide bond in its receptor.
引入尿激酶受体中非天然的结构域间二硫键模拟其在片状伪足形成中的调节作用。
J Biol Chem. 2011 Dec 16;286(50):43515-26. doi: 10.1074/jbc.M111.300020. Epub 2011 Oct 24.
4
Conformational regulation of urokinase receptor function: impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia induction.尿激酶受体功能的构象调节:受体占据和表位映射单克隆抗体对片状伪足诱导的影响。
J Biol Chem. 2011 Sep 23;286(38):33544-56. doi: 10.1074/jbc.M111.220087. Epub 2011 Jul 28.
5
Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?纤溶酶原激活物抑制剂-1是控制尿激酶受体介导的细胞黏附和释放的分子开关吗?
J Cell Biol. 1996 Sep;134(6):1563-71. doi: 10.1083/jcb.134.6.1563.